Register entry

Bamboo US BidCo LLC

Data as of · How to read this entry

Registered sites
2
Active NDC listings
6
Live patents
0
Countries
2
Base
United States
Authorisation

Registered operations

Analytical testing2Active ingredient (API) manufacture1Labelling2Finished drug manufacture2Packaging2particle size reduction1Relabelling1sterilize2
Sites

Registered establishments

2
EstablishmentAddressRegistered forFEI / DUNS
Simtra Deutschland GmbHRegistrant: Bamboo US BidCo LLCKantstrasse 2, Halle/Westfalen, 33790, Germany (DEU)Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging, particle size reduction, sterilize3002806419344276063
Simtra US LLCRegistrant: Bamboo US BidCo LLC927 South Curry Pike, Bloomington, Indiana (IN) 47403, United States (USA)Analytical testing, Labelling, Finished drug manufacture, Packaging, Relabelling, sterilize1000115571604719430
Catalogue

Drug listings by form and route

6

6 active NDC listings: 5 vaccine, 1 drug for further processing. By marketing category: BLA 5, DRUG FOR FURTHER PROCESSING 1.

Dosage formNDCs
injection, suspension4
injection, powder, lyophilized, for solution1
injection, solution1
RouteNDCs
intramuscular5
subcutaneous2
Labeller name on the listingNDCs
bamboo us bidco llc6
Catalogue

Marketed products

6
BrandGeneric nameForm / routeNDC
FLUZONE TRIVALENT NORTHERN HEMISPHEREINFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136/RV/2023 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)injection, suspension, intramuscular83703-087BLA
FlucelvaxINFLUENZA A VIRUS A/Georgia/12/2022 CVR-167 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Victoria/800/2024 CVR-289 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Singapore/WUH4618/2021 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)injection, suspension, intramuscular83703-088BLA
HEPLISAV-BHepatitis B Vaccine (Recombinant) Adjuvantedinjection, solution, intramuscular83703-048BLA
RECOMBIVAX HBHepatitis B Vaccine (Recombinant)injection, suspension, intramuscular, subcutaneous83703-085BLA
RECOMBIVAX HBHepatitis B Vaccine (Recombinant)injection, suspension, intramuscular, subcutaneous83703-086BLA
-choriogonadotropin alfainjection, powder, lyophilized, for solution83703-001DRUG FOR FURTHER PROCESSING
Neighbours

Registered in the same town

2
Compare

Comparable companies in United States

Enquiry

Common questions

Is Bamboo US BidCo LLC FDA approved?
Bamboo US BidCo LLC holds 2 FDA-registered establishments across 2 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Bamboo US BidCo LLC's drugs manufactured?
At registered sites in Germany, the United States. The FDA register lists Halle/Westfalen; Bloomington, IN. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, finished drug manufacture, packaging, particle size reduction, relabelling, sterilize.
What drugs does Bamboo US BidCo LLC make?
6 products are listed under Bamboo US BidCo LLC in the openFDA NDC Directory, most often as injection, suspension; injection, powder, lyophilized, for solution; injection, solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.